🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to investigate the impact of sugar levels in cigar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2022-02-24
Trial ID
NCT05308316
Treatments Being Tested
This is a single-center, open-label, parallel-cohort study to measure and c...
Status
Completed
Location
Clinical Research Atlanta
Start Date
2022-05-23
Trial ID
NCT05363254
A single-center, randomized, controlled, partially blinded, crossover study...
Status
Active Not Recruiting
Location
Celerion
Start Date
2025-07-17
Trial ID
NCT07135648
Treatments Being Tested
The central objective of the project is to evaluate the effect of incorpora...
Status
Completed
Location
Duke Medical Center
Start Date
2015-10-08
Trial ID
NCT02538042
Treatments Being Tested
This is a two-site, open-label, randomized, 6-way cross-over study designed...
Status
Completed
Location
AMR Lexington
Start Date
2022-05-01
Trial ID
NCT05294497
This is a randomized, open-label, 6-way crossover, multi-site study designe...
Status
Completed
Location
QPS Bio-Kinetic
Start Date
2022-03-21
Trial ID
NCT05210699
Cigarette smokers will be randomized to E-cigarette, Nicotine Gum or Lozeng...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2015-05
Trial ID
NCT03111537
Treatments Being Tested
Although the well-known detrimental effects of conventional cigarette smoki...
Status
Completed
Location
Addendo srl
Start Date
2021-10-18
Trial ID
NCT04649645
Treatments Being Tested
This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study ...
Status
Recruiting
Location
Dr. Vince Clinical Research
Start Date
2025-12-15
Trial ID
NCT07132814
The purpose of this study is to assess changes in exposure to selected harm...
Status
Completed
Location
Celerion
Start Date
2019-03-01
Trial ID
NCT04019626